MediPal Holdings Corporation (TYO:7459)
Japan · Delayed Price · Currency is JPY 2,926.50
+17.50 (0.60%)
Aug 26, 2026, 11:13 AM JST
MediPal Holdings Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 3,861,698 | 3,817,354 | 3,671,328 | 3,558,732 | 3,360,008 | 3,290,921 | |
Revenue Growth | 4.17% | 3.98% | 3.16% | 5.91% | 2.10% | 2.48% |
Cost of Revenue | 3,599,655 | 3,556,366 | 3,415,569 | 3,312,077 | 3,135,703 | 3,073,476 |
Gross Profit | 262,043 | 260,988 | 255,759 | 246,655 | 224,305 | 217,445 |
Selling, General & Admin | 195,790 | 194,224 | 186,634 | 185,677 | 163,143 | 159,487 |
Operating Expenses | 209,530 | 207,804 | 200,148 | 199,324 | 175,331 | 171,820 |
Operating Income | 52,513 | 53,184 | 55,611 | 47,331 | 48,974 | 45,625 |
Interest Expense | -13 | -13 | -7 | -8 | -34 | -16 |
Interest & Investment Income | 7,658 | 7,703 | 3,142 | 2,790 | 2,635 | 2,708 |
Earnings From Equity Investments | 3,940 | 3,907 | -3,768 | 3,584 | 3,590 | 3,484 |
Other Non Operating Income (Expenses) | 11,308 | 10,940 | 10,275 | 10,873 | 9,957 | 10,243 |
EBT Excluding Unusual Items | 75,406 | 75,721 | 65,253 | 64,570 | 65,122 | 62,044 |
Gain (Loss) on Sale of Investments | 25,583 | 20,818 | 11,819 | 9,764 | 6,855 | -917 |
Gain (Loss) on Sale of Assets | -47 | -180 | -397 | -141 | -147 | -32 |
Asset Writedown | -10,208 | -10,213 | -278 | -707 | -266 | -100 |
Other Unusual Items | -4,780 | -4,303 | 335 | 1,254 | -1,503 | -3,713 |
Pretax Income | 86,876 | 81,843 | 76,732 | 74,740 | 70,061 | 57,282 |
Income Tax Expense | 30,405 | 28,703 | 25,203 | 22,973 | 21,738 | 18,087 |
Earnings From Continuing Operations | 56,471 | 53,140 | 51,529 | 51,767 | 48,323 | 39,195 |
Minority Interest in Earnings | -9,877 | -10,606 | -11,250 | -10,293 | -9,517 | -9,772 |
Net Income | 46,594 | 42,534 | 40,279 | 41,474 | 38,806 | 29,423 |
Net Income to Common | 46,594 | 42,534 | 40,279 | 41,474 | 38,806 | 29,423 |
Net Income Growth | 14.04% | 5.60% | -2.88% | 6.88% | 31.89% | 22.98% |
Shares Outstanding (Basic) | 205 | 206 | 208 | 212 | 210 | 210 |
Shares Outstanding (Diluted) | 205 | 206 | 208 | 212 | 216 | 223 |
Shares Change | -0.87% | -1.29% | -1.55% | -2.11% | -3.04% | 0.03% |
EPS (Basic) | 227.21 | 206.67 | 193.19 | 195.83 | 184.82 | 140.13 |
EPS (Diluted) | 227.21 | 206.67 | 193.19 | 195.83 | 179.12 | 131.41 |
EPS Growth | 15.65% | 6.98% | -1.35% | 9.33% | 36.31% | 23.04% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 39,933 | 51,698 | 46,283 | 5,663 | 45,258 |
Free Cash Flow Per Share | - | 194.03 | 247.96 | 218.54 | 26.18 | 202.84 |
Dividend Per Share | 66.000 | 66.000 | 62.000 | 60.000 | 46.000 | 44.000 |
Dividend Growth | 6.45% | 6.45% | 3.33% | 30.44% | 4.54% | 4.76% |
Gross Margin | 6.79% | 6.84% | 6.97% | 6.93% | 6.68% | 6.61% |
Operating Margin | 1.36% | 1.39% | 1.52% | 1.33% | 1.46% | 1.39% |
Profit Margin | 1.21% | 1.11% | 1.10% | 1.17% | 1.16% | 0.89% |
Free Cash Flow Margin | - | 1.05% | 1.41% | 1.30% | 0.17% | 1.38% |
EBITDA | 83,150 | 81,377 | 74,028 | 65,313 | 63,622 | 59,963 |
EBITDA Margin | 2.15% | 2.13% | 2.02% | 1.84% | 1.89% | 1.82% |
D&A For EBITDA | 30,637 | 28,193 | 18,417 | 17,982 | 14,648 | 14,338 |
EBIT | 52,513 | 53,184 | 55,611 | 47,331 | 48,974 | 45,625 |
EBIT Margin | 1.36% | 1.39% | 1.52% | 1.33% | 1.46% | 1.39% |
Effective Tax Rate | 35.00% | 35.07% | 32.84% | 30.74% | 31.03% | 31.57% |